owcp

wolmed.com
OWCP Federal Injured Workers Don’t Have to See a Company Doctor

We had a new federal OWCP work injury patient who called us a couple of weeks ago because he was hurt while working as a letter carrier for the post office.  After he made his appointment to see the doctor, he called back and told us that he was told that he had to go see his company doctor first.  What company doctor?  He was surprised to learn that the post office doesn’t have a company doctor.  The Federal Employee Compensation Act (FECA) allows for any injured federal employee to go to any medical doctor for their OWCP work injury.  Fortunately for this man, he was able to come see a WOLMED doctor that is specially trained to help injured federal employees from the United States Postal Service.  

The Office of Workers' Compensation Programs


Seal of the United States Department of Energy. (Photo credit: Wikipedia)

http://ping.fm/9Wuoc The Office of Workers’ Compensation Programs (OWCP) is publishing a list of Department of Energy (DOE) facilities covered under the Energy Employees Occupational Illness Compensation Program Act of 2000, as amended (EEOICPA). This notice revises and republishes the listing of DOE facilities that was last published by OWCP on November 24, 2010 (75 FR 71737) to include additional determinations made on this subject through March 6, 2012.

bit.ly
One World Cannabis to Offer New Alternative Treatment for Chronic Pain in Light Of FDA’s NSAIDs Warning

OWC s Research & Development For New Chronic Pain Treatments Occurs As FDA Calls To Increase Existing Heart Attack And Stroke Warnings For NSAIDs PETACH TIKVA, Israel, July 15, 2015 /PRNewswire/ OWC Pharmaceutical Research Corp. (OTCQB: OWCP), an Israeli-based developer of cannabinoid-based therapies targeting a variety of different indications, is offering new and alternative hope to patients diagnosed with chronic pain. The company s wholly owned subsidiary, One World Cannabis Ltd., has already filed two provisional patent applications with the USPTO related to the development of two unique formulations that include cannabis extracts and a new delivery system to treat fibromyalgia and migraines, and has begun researching and developing new cannabis-based therapies to help alleviate the suffering of patients experiencing enduring pain. (Logo: http://photos.prnewswire.com/prnh/20150311/734965-a ) (Logo: http://photos.prnewswire.com/prnh/20150311/734965-b ) The news comes about after t